A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)
Version of Record online: 18 APR 2014
© 2014 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Volume 120, Issue 15, pages 2343–2351, August 1, 2014
How to Cite
Bepler, G., Zinner, R. G., Moon, J., Calhoun, R., Kernstine, K., Williams, C. C., Mack, P. C., Oliveira, V., Zheng, Z., Stella, P. J., Redman, M. W. and Gandara, D. R. (2014), A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701). Cancer, 120: 2343–2351. doi: 10.1002/cncr.28714
- Issue online: 21 JUL 2014
- Version of Record online: 18 APR 2014
- Manuscript Accepted: 18 MAR 2014
- Manuscript Revised: 17 MAR 2014
- Manuscript Received: 10 FEB 2014
- 3Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small-cell lung cancer: report of the Cancer and Leukemia Group B protocol 9633 [abstract]. Proc Am Soc Clin Oncol. 2004;23:Page. Abstract 7019., , , et al.
- 4Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol. 2008;26:5043-5051., , , et al.
- 22Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7:719-727., , , et al.
- 24The Big Lung Trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer. Preliminary results in the surgical setting. Lung Cancer. 2003;41:54., , , et al.
- 25International Staging Committee and Participating Institutions. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol. 2009;4:792-801., , , , , ;
- 27ERCC1 isoform expression and DNA repair in non-small-cell lung cancer. N Engl J Med. 2013;369:1101-1110., , , et al.
- 30CCTα is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in lung and head and neck squamous cell carcinomas. Cancer. In press., , , et al.